Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
13.98
-0.33 (-2.31%)
At close: Feb 21, 2025, 4:00 PM
14.04
+0.06 (0.43%)
After-hours: Feb 21, 2025, 4:19 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $1.08 billion as of February 21, 2025. Its market cap has increased by 138.30% in one year.
Market Cap
1.08B
Enterprise Value
616.17M
1-Year Change
138.30%
Ranking
Category
Stock Price
$13.98
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $1.08B, an increase of 130.30%. That is a compound annual growth rate of 13.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |